tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 239 are a BUY (83.86%), 46 are a HOLD (16.14%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 54.61% that have a potential upside of 38.81% achieved within 318 days.
Michael Schmidt’s has documented 523 price targets and ratings displayed on 60 stocks. The coverage is on Healthcare, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on GLUE, Monte Rosa Therapeutics at 30-Jun-2026.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 3/27/2026. The price target of $6 was fulfilled within 14 days with a profit of $3.9 (185.71%) receiving and performance score of 132.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
4 years 24 days ago
(14-Jun-2022)
0/13 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
4 years 8 months 5 days ago
(03-Nov-2021)
8/10 (80%)
$0.06 (1.28%)
66
Sell Since 20-May-2020
$3
$2.91 (3233.33%)
5 years 8 months 2 days ago
(06-Nov-2020)
3/5 (60%)
$-1.26 (-29.58%)
151
Buy Since 09-May-2018
$16
$15.91 (17677.78%)
$17
5 years 11 months 1 days ago
(07-Aug-2020)
4/11 (36.36%)
$10.58 (195.20%)
88
Sell Since 08-Oct-2019
6 years 2 months 2 days ago
(06-May-2020)
0/2 (0%)
$25.85 (43.70%)
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
